Not available
Quote | GlaxoSmithKline PLC (NYSE:GSK)
Last: | $42.935 |
---|---|
Change Percent: | -0.13% |
Open: | $43 |
Close: | $42.99 |
High: | $43.22 |
Low: | $42.915 |
Volume: | 1,512,947 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | GlaxoSmithKline PLC (NYSE:GSK)
2024-03-25 13:47:00 ET Summary Boeing's top boss Dave Calhoun plans to step down at the end of the year. Mizuho turns cautious on the EV sector, downgrades Tesla, Rivian, and Nio. Look beyond the Magnificent 7 to the GRANOLAS in Europe - Goldman Sachs. Listen below o...
2024-03-25 02:07:51 ET Summary Sanofi has underperformed the U.S. stock market lately but now offers one of the smartest growth-at-a-reasonable-price setups in Big Pharma. Sanofi is best known for its patented drug Dupixent and numerous vaccines manufactured for global use, which ...
Message Board Posts | GlaxoSmithKline PLC (NYSE:GSK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $GSK News Article - Global pharma giants partner Singapore researchers to boost innovat | whytestocks | investorshangout | 12/06/2022 7:20:45 PM |
whytestocks: $GSK News Article - Spero Therapeutics Announces Closing of Exclusive License Agreement | whytestocks | investorshangout | 11/08/2022 1:30:52 PM |
whytestocks: $GSK News Article - 3 Dirt-Cheap Stocks That Could Soar 48% to 68%, According to Wall S | whytestocks | investorshangout | 10/07/2022 3:15:49 PM |
Post hoc analysis shows that biomarker correlates with | jondoeuk | investorshub | 09/13/2022 4:41:37 PM |
$GSK Total Debt is $22.11 Billion // $8.00 | BottomBounce | investorshub | 08/11/2022 1:02:19 PM |
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
On Wednesday, GSK Plc (NYSE:GSK) announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month ...
Saturday, GSK plc (NYSE:GSK) announced overall survival (OS) results from Part 1 and progression-free survival (PFS) results fr...
Pfizer Inc (NYSE:PFE) plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc (NYSE:HLN)&nbs...